Literature DB >> 25439351

The allergic asthma phenotype.

Michael Schatz1, Lanny Rosenwasser2.   

Abstract

Allergic asthma is the most common asthma phenotype. It usually is defined by the presence of sensitization to environmental allergens, although a clinical correlation between exposure and symptoms further supports the diagnosis. The average age of onset of allergic asthma is younger than that of nonallergic asthma. Although the spectrum of allergic asthma may vary from mild to severe, studies have reported that allergic versus nonallergic asthma is less severe. There is an increased prevalence of allergic rhinoconjunctivitis and atopic dermatitis in patients with allergic asthma. Total IgE levels usually are higher in allergic versus nonallergic asthma, but levels substantially overlap between the 2 groups. Increased Th2 cytokines have been demonstrated in secretions and peripheral blood of patients with allergic asthma. Atopy has been reported to be inversely associated with persistent airflow obstruction and airway remodeling. Clusters with a high prevalence of early onset atopic asthma have been frequently reported in statistical phenotyping studies, but the various clusters of patients with atopy were quite heterogeneous in terms of symptom severity, pulmonary function, and tendency for exacerbations. Implications for future research regarding the allergic asthma phenotype are described.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergic asthma; Allergic sensitization; Asthma; Asthma phenotypes

Mesh:

Substances:

Year:  2014        PMID: 25439351     DOI: 10.1016/j.jaip.2014.09.004

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  57 in total

1.  IL-1RA regulates immunopathogenesis during fungal-associated allergic airway inflammation.

Authors:  Matthew S Godwin; Kristen M Reeder; Jaleesa M Garth; Jonathan P Blackburn; MaryJane Jones; Zhihong Yu; Sadis Matalon; Annette T Hastie; Deborah A Meyers; Chad Steele
Journal:  JCI Insight       Date:  2019-11-01

Review 2.  Targeting patients with asthma for omalizumab therapy: choosing the right patient to get the best value for money.

Authors:  Abir Al Said; Breda Cushen; Richard W Costello
Journal:  Ther Adv Chronic Dis       Date:  2017-02-01       Impact factor: 5.091

Review 3.  Vaccine Potential of Mycobacterial Antigens against Asthma.

Authors:  Abu Salim Mustafa
Journal:  Med Princ Pract       Date:  2020-05-18       Impact factor: 1.927

4.  Allergic Endotypes and Phenotypes of Asthma.

Authors:  Nicole Akar-Ghibril; Thomas Casale; Adnan Custovic; Wanda Phipatanakul
Journal:  J Allergy Clin Immunol Pract       Date:  2020-02

Review 5.  Rhinoviruses and Their Receptors: Implications for Allergic Disease.

Authors:  Yury A Bochkov; James E Gern
Journal:  Curr Allergy Asthma Rep       Date:  2016-04       Impact factor: 4.806

Review 6.  Nanoparticle-based CpG-oligonucleotide therapy for treating allergic asthma.

Authors:  Brittany E Givens; Sean M Geary; Aliasger K Salem
Journal:  Immunotherapy       Date:  2018-03-23       Impact factor: 4.196

7.  Asthma and Hypogammaglobulinemia: an Asthma Phenotype with Low Type 2 Inflammation.

Authors:  Clairelyne Dupin; Sylvain Marchand-Adam; Olivier Favelle; Romain Costes; Philippe Gatault; Philippe Diot; Leslie Grammatico-Guillon; Laurent Guilleminault
Journal:  J Clin Immunol       Date:  2016-10-06       Impact factor: 8.317

8.  Meteorin-β/Meteorin like/IL-41 attenuates airway inflammation in house dust mite-induced allergic asthma.

Authors:  Xun Gao; Ting-Fan Leung; Gary Wing-Kin Wong; Wing-Hung Ko; Mengyun Cai; Ellie Jiayi He; Ida Miu-Ting Chu; Miranda Sin-Man Tsang; Ben Chung-Lap Chan; Jiawei Ling; Xiao Fan; Liwei Lu; Christopher Wai-Kei Lam; Chun-Kwok Wong
Journal:  Cell Mol Immunol       Date:  2021-11-30       Impact factor: 11.530

Review 9.  The use of biologic therapies for the management of pediatric asthma.

Authors:  Stephanie Lovinsky-Desir
Journal:  Pediatr Pulmonol       Date:  2019-12-27

10.  The Impact of Interleukin (IL)-33 Gene Polymorphisms and Environmental Factors on Risk of Asthma in the Iranian Population.

Authors:  Mojdeh Matloubi; Maral Ranjbar; Mohammad-Ali Assarehzadegan; Morteza Fallahpour; Fatemeh Sadeghi; Saeed Soleyman-Jahi; Leila Janani
Journal:  Lung       Date:  2019-12-09       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.